PPWP
RMD icon

Premier Path Wealth Partners’s ResMed RMD Stock Holding History

Premier Path Wealth Partners’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$304K Sell
1,562
-151
-9% -$31.3K 0.04% 358
2026
Q1 		$384K Buy
1,713
+334
+24% +$83.2K 0.05% 312
2025
Q4 		$332K Sell
1,379
-97
-7% -$24.8K 0.04% 312
2025
Q3 		$404K Buy
1,476
+171
+13% +$46.7K 0.05% 289
2025
Q2 		$337K Buy
1,305
+161
+14% +$38.4K 0.05% 308
2025
Q1 		$256K Buy
1,144
+8
+0.7% +$1.87K 0.04% 328
2024
Q4 		$260K Buy
1,136
+28
+3% +$6.74K 0.04% 324
2024
Q3 		$270K Buy
1,108
+32
+3% +$7.15K 0.04% 318
2024
Q2 		$206K Buy
+1,076
New +$218K 0.04% 353

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Premier Path Wealth Partners's RMD Position: Q2 2026 in Review

Premier Path Wealth Partners reduced its ResMed (RMD) stake by 8.8% in Q2 2026, selling an estimated $31.3K and leaving 1,562 shares worth $304K. The position accounts for 0.04% of the portfolio, ranked #358.

Premier Path Wealth Partners first reported a position in RMD in Q2 2024 and has held it in 9 quarters since. The position peaked at $404K in Q3 2025. 887 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Premier Path Wealth Partners held 1,562 shares of ResMed worth $304K as of Q2 2026.
  • Premier Path Wealth Partners sold 151 ResMed shares in Q2 2026, an estimated $31.3K.
  • ResMed made up 0.04% of Premier Path Wealth Partners's portfolio in Q2 2026, its #358 holding.
  • Premier Path Wealth Partners first reported a position in ResMed in Q2 2024 and has held it in 9 quarters since.
  • Premier Path Wealth Partners's ResMed position peaked at $404K in Q3 2025.
  • 887 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Premier Path Wealth Partners's 13F filing for Q2 2026, filed 21 Jul 2026.